Russell Investments Group
APGE icon

Russell Investments Group’s Apogee Therapeutics APGE Stock Holding History

Russell Investments Group’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Sell
32,687
-25,797
-44% -$2.32M ﹤0.01% 1601
2026
Q1 		$4.92M Buy
58,484
+8,485
+17% +$616K 0.01% 1355
2025
Q4 		$3.77M Buy
49,999
+6,326
+14% +$398K ﹤0.01% 1494
2025
Q3 		$1.74M Buy
43,673
+21,905
+101% +$836K ﹤0.01% 1932
2025
Q2 		$945K Buy
21,768
+21,564
+10,571% +$820K ﹤0.01% 2086
2025
Q1 		$7.62K Buy
204
+16
+9% +$619 ﹤0.01% 3288
2024
Q4 		$8.52K Hold
188
– – ﹤0.01% 3172
2024
Q3 		$11K Sell
188
-1,319
-88% -$63.2K ﹤0.01% 3060
2024
Q2 		$59.3K Buy
+1,507
New +$73.1K ﹤0.01% 2728

Other funds holding APGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Russell Investments Group's APGE Position: Q2 2026 in Review

Russell Investments Group reduced its Apogee Therapeutics (APGE) stake by 44% in Q2 2026, selling an estimated $2.32M and leaving 32,687 shares worth $4.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

Russell Investments Group first reported a position in APGE in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.92M in Q1 2026. 101 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Russell Investments Group held 32,687 shares of Apogee Therapeutics worth $4.34M as of Q2 2026.
  • Russell Investments Group sold 25,797 Apogee Therapeutics shares in Q2 2026, an estimated $2.32M.
  • Apogee Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1601 holding.
  • Russell Investments Group first reported a position in Apogee Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Russell Investments Group's Apogee Therapeutics position peaked at $4.92M in Q1 2026.
  • 101 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.